openIOWA CITY, IA

How SAMHD1 regulates HIV-1 innate immunity and viral gene expression

National Institute of Allergy and Infectious Diseases

Description

The lack of clear mechanisms by which host proteins regulate HIV-1 innate immunity in macrophages is a significant knowledge barrier to a functional cure for HIV-1 persistent infection. In this revised R01 proposal, we seek to investigate non-canonical functions of the cellular protein sterile alpha motif and HD domain-containing protein 1 (SAMHD1) in regulating innate immune responses during HIV-1 infection of primary macrophages. Since SAMHD1 was discovered as an HIV-1 restriction factor in 2011, extensive studies have revealed the mechanisms underlying SAMHD1-mediated restriction of HIV-1 replication in myeloid cells and resting CD4+ T cells. In 2018, we discovered a novel function of SAMHD1 in suppressing the innate immune response to viral infections and inflammation in macrophages. However, the underlying mechanisms of action remain unclear, representing a significant knowledge gap given the importance of macrophages in HIV-1 persistence. Our long-term goal is to define the functional roles and molecular mechanisms of cellular proteins, such as SAMHD1, in regulating innate immunity during persistent HIV-1 infection of macrophages. Our overall objective is to reveal how SAMHD1 inhibits the type I interferon (IFN-I) and NF-κB pathways in primary macrophages, acting as a multifaceted repressor of innate immune signaling induced by viral infection. IFN-I induction plays a key role in antiviral innate immunity; however, HIV-1 infection does not induce a strong IFN-I response. NF-κB is critical for HIV-1 gene transcription and immune activation, and transcriptional inhibition of viral gene expression is the main mechanism of HIV-1 latency. Thus, our central hypothesis is that SAMHD1 suppresses innate immunity to HIV-1 infection in primary macrophages by inhibiting IFN-I induction and NF-κB activation. Our three specific aims are: Aim 1. Define how SAMHD1 and IRF7 interaction inhibits IFN-I induction during HIV-1 infection; Aim 2. Examine SAMHD1 interaction with MAVS and effects on anti-HIV-1 innate immune responses; Aim 3. Investigate the mechanisms by which SAMHD1 inhibits NF-kB activation during HIV-1 infection. Our interdisciplinary studies will fill knowledge gaps to fundamentally enhance our mechanistic understanding of SAMHD1 and associated proteins in regulating HIV-1 infection, viral gene expression, immune activation, and anti-HIV-1 innate immune responses. Thus, our proposed studies of how SAMHD1 regulates immune activation and HIV-1 infection in macrophages will provide new knowledge studying viral persistence. Project Number: 1R01AI189220-01A1 | Fiscal Year: 2025 | NIH Institute/Center: National Institute of Allergy and Infectious Diseases (NIAID) | Principal Investigator: Li Wu | Institution: UNIVERSITY OF IOWA, IOWA CITY, IA | Award Amount: $769,414 | Activity Code: R01 | Study Section: HIV Molecular Virology, Cell Biology, and Drug Development Study Section[HVCD] View on NIH RePORTER: https://reporter.nih.gov/project-details/1R01AI18922001A1

Interested in this grant?

Sign up to get match scores, save grants, and start your application with AI-powered tools.

Start Free Trial

Grant Details

Funding Range

$769,414 - $769,414

Deadline

June 30, 2030

Geographic Scope

IOWA CITY, IA

Status
open

External Links

View Original Listing

Want to see how well this grant matches your organization?

Get Your Match Score

Get personalized grant matches

Start your free trial to save opportunities, get AI-powered match scores, and manage your applications in one place.

Start Free Trial